Patient participation in psoriasis and psoriatic arthritis outcome research: A report from the GRAPPA 2013 annual meeting

Journal of Rheumatology

Volumn 41, Issue 6, 2014, Pages 1206-1211

  De Wit, Maarten ^h   Campbell, Willemina ^b   FitzGerald, Oliver ^a   Gladman, Dafna D ^b   Helliwell, Phillip S ^c   James, Jana ^d   Lindsay, Chris ^h   MacDonald, Roland ^b   McHugh, Neil J ^d   Mease, Philip J ^e   Orbai, Ana Maria ^f   Palominos, Penélope ^g   Parkinson, Andrew ^c   Tillett, William ^d   Goel, Niti ^h  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^h Royal National Hospital for Rheumatic Diseases ^*

Author keywords

Outcome research; Patient involvement; Patient research partner; Patient reported outcomes; Psoriatic arthritis

Indexed keywords

CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; CONFERENCE PAPER; DISEASE ACTIVITY; HUMAN; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RESEARCH SUBJECT; SELF REPORT; SYSTEMATIC REVIEW (TOPIC); TREATMENT PLANNING; MEDICAL RESEARCH;

ARTHRITIS, PSORIATIC; BIOMEDICAL RESEARCH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PSORIASIS;

EID: 84901712548     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140171     Document Type: Conference Paper

References (32)

1. Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Ann Rev Public Health 1998;19:173-202. (Pubitemid 28279929)
2. (FDA), U.S.D.H.H.S.F.D.A. Guidance for Industry - Patient-reported outcome measures: Use in medical product development to support labeling claims; 2009. [Internet. Accessed March 18, 2014.] Available from: www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
3. Richards P, de Wit MPT. OMERACT glossary 2012 [updated 2012 May] [Internet. Accessed March 18, 2014.] Available from: www.omeract.org/pdf/ OMERACT11%20Glossary.pdf
4. OMERACT. Guiding principles for patient research partner participation in OMERACT, V1.0; 2011. [Internet. Accessed March 18, 2014.] Available from: www.omeract.org/pdf/2011-03-27%20Agreed%20Patient%20Participation%20Policy.pdf
5. OMERACT. Outcome measures in rheumatology. Home page; 2013 [Internet. Accessed March 18, 2014.] Available from: www.omeract.org/
6. National Institute for Health Research. Central Commissioning Facility National Institute for Health Research and Policy Research Programme Patient and Public Involvement Plan: Purpose, objectives and work (April 2013 to March 2015). [Internet. Accessed March 18, 2014.] Available from: www.ccf.nihr.ac.uk/ PPI/Documents/CCF%20PPI%20Plan%202013-15.pdf
7. Gossec L, de Wit M, Heiberg T, Maccarone M, Balanescu A, Balint P, et al. Elaboration and preliminary validation of the psoriatic arthritis impact of disease (PSAID) questionnaire. A 13-country EULAR initiative with involvement of patient research partners from each country [abstract]. Ann Rheum Dis 2013;72 Suppl 3:89.
8. Tillett W, Adebajo A, Brooke M, Campbell I, Coates L, Fitzgerald O, et al. Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep 2014;16:418.
9. Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale JD, et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 2011;70:272-7.
10. Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 2013;72:986-91.
11. de Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open 2013;3 pii:e002241.
12. de Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences - lessons learnt from a decade of collaboration in OMERACT: a qualitative study. BMJ Open 2013;3:e003311.
13. Dandorfer SW, Rech J, Manger B, Schett G, Englbrecht M. Differences in the patient's and the physician's perspective of disease in psoriatic arthritis. Semin Arthritis Rheum 2012;42:32-41.
14. de Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis 2011;70:722-6.
15. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9. (Pubitemid 38122135)
16. Taylor WJ. Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods. Ann Rheum Dis 2005;64 Suppl 2:ii110-2. (Pubitemid 40288538)
17. Gladman DD. Consensus exercise on domains in psoriatic arthritis. Ann Rheum Dis 2005;64 Suppl 2:ii113-4. (Pubitemid 40288539)
18. Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, FitzGerald O, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70. (Pubitemid 46774868)
19. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8. (Pubitemid 32954441)
20. Short P, Jones AC, Walker D, Kavanaugh A, Moots RJ. Working at arthritis. Rheumatology 2012;51:201-3.
21. Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology 2012;51:275-83.
22. Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum 2007;57:487-94. (Pubitemid 46682538)
23. Palominos PE, Gaujoux-Viala C, Fautrel B, Dougados M, Gossec L. Clinical outcomes in psoriatic arthritis: a systematic literature review. Arthritis Care Res 2012;64:397-406.
24. Barton JL. Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence 2009;3:335-44.
25. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005;44:762-7. (Pubitemid 41487205)
26. de Thurah A, Norgaard M, Harder I, Stengaard-Pedersen K. Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study. Rheumatol Int 2010;30:1441-8.
27. Niu NN, Davis AM, Bogart LM, Thornhill TS, Abreu LA, Ghazinouri R, et al. Patient disease perceptions and coping strategies for arthritis in a developing nation: a qualitative study. BMC Musculoskelet Disord 2011;12:228.
28. Salminen E, Heikkila S, Poussa T, Lagstrom H, Saario R, Salminen S. Female patients tend to alter their diet following the diagnosis of rheumatoid arthritis and breast cancer. Prev Med 2002;34:529-35. (Pubitemid 34971676)
29. Groarke A, Curtis R, Coughlan R, Gsel A. The role of perceived and actual disease status in adjustment to rheumatoid arthritis. Rheumatology 2004;43:1142-9. (Pubitemid 39232820)
30. Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res 2010;62:791-9.
31. Gladman DD, Tom BD, Mease PJ, Farewell VT. Informing response criteria for psoriatic arthritis (PsA). II: Further considerations and a proposal - the PsA joint activity index. J Rheumatol 2010;37:2559-65.
32. Nell-Duxneuner VP, Stamm TA, Machold KP, Pflugbeil S, Aletaha D, Smolen JS. Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis. Ann Rheum Dis 2010;69:546-9.